105 related articles for article (PubMed ID: 24794893)
1. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.
Amar-Lewis E; Azagury A; Chintakunta R; Goldbart R; Traitel T; Prestwood J; Landesman-Milo D; Peer D; Kost J
J Control Release; 2014 Jul; 185():109-20. PubMed ID: 24794893
[TBL] [Abstract][Full Text] [Related]
2. Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.
Kim B; Park JH; Sailor MJ
Adv Mater; 2019 Dec; 31(49):e1903637. PubMed ID: 31566258
[TBL] [Abstract][Full Text] [Related]
3. Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications.
Gupta K; Afonin KA; Viard M; Herrero V; Kasprzak W; Kagiampakis I; Kim T; Koyfman AY; Puri A; Stepler M; Sappe A; KewalRamani VN; Grinberg S; Linder C; Heldman E; Blumenthal R; Shapiro BA
J Control Release; 2015 Sep; 213():142-151. PubMed ID: 26151705
[TBL] [Abstract][Full Text] [Related]
4. Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes.
Qiu C; Han HH; Sun J; Zhang HT; Wei W; Cui SH; Chen X; Wang JC; Zhang Q
Nat Commun; 2019 Jun; 10(1):2702. PubMed ID: 31221991
[TBL] [Abstract][Full Text] [Related]
5. Amylose-Based Cationic Star Polymers for siRNA Delivery.
Nishimura T; Umezaki K; Mukai SA; Sawada S; Akiyoshi K
Biomed Res Int; 2015; 2015():962941. PubMed ID: 26539548
[TBL] [Abstract][Full Text] [Related]
6. The landscape of nanoparticle-based siRNA delivery and therapeutic development.
Moazzam M; Zhang M; Hussain A; Yu X; Huang J; Huang Y
Mol Ther; 2024 Feb; 32(2):284-312. PubMed ID: 38204162
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.
Kaneda MM; Sasaki Y; Lanza GM; Milbrandt J; Wickline SA
Biomaterials; 2010 Apr; 31(11):3079-86. PubMed ID: 20092889
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous Silica Nanoparticles Mediate SiRNA Delivery for Long-Term Multi-Gene Silencing in Intact Plants.
Cai Y; Liu Z; Wang H; Meng H; Cao Y
Adv Sci (Weinh); 2024 Mar; 11(9):e2301358. PubMed ID: 38145358
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of Piperazine-Based Compounds Conjugated to Humanized Ferritin as Delivery System of siRNA in Cancer Cells.
Pediconi N; Ghirga F; Del Plato C; Peruzzi G; Athanassopoulos CM; Mori M; Crestoni ME; Corinti D; Ugozzoli F; Massera C; Arcovito A; Botta B; Boffi A; Quaglio D; Baiocco P
Bioconjug Chem; 2021 Jun; 32(6):1105-1116. PubMed ID: 33978420
[TBL] [Abstract][Full Text] [Related]
10. Cytocompatibility, membrane disruption, and siRNA delivery using environmentally responsive cationic nanogels.
Spencer DS; Shodeinde AB; Beckman DW; Luu BC; Hodges HR; Peppas NA
J Control Release; 2021 Apr; 332():608-619. PubMed ID: 33675879
[TBL] [Abstract][Full Text] [Related]
11. Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy.
Naghib SM; Ahmadi B; Mozafari MR
Curr Med Chem; 2024 Jun; ():. PubMed ID: 38847253
[TBL] [Abstract][Full Text] [Related]
12. Two-Photon Light Trigger siRNA Transfection of Cancer Cells Using Non-Toxic Porous Silicon Nanoparticles.
Chaix A; Cueto-Diaz E; Dominguez-Gil S; Spiteri C; Lichon L; Maynadier M; Dumail X; Aggad D; Delalande A; Bessière A; Pichon C; Chiappini C; Sailor MJ; Bettache N; Gary-Bobo M; Durand JO; Nguyen C; Cunin F
Adv Healthc Mater; 2023 Oct; 12(27):e2301052. PubMed ID: 37499629
[TBL] [Abstract][Full Text] [Related]
13. Sticky nanoparticles: a platform for siRNA delivery by a bis(zinc(II) dipicolylamine)-functionalized, self-assembled nanoconjugate.
Liu G; Choi KY; Bhirde A; Swierczewska M; Yin J; Lee SW; Park JH; Hong JI; Xie J; Niu G; Kiesewetter DO; Lee S; Chen X
Angew Chem Int Ed Engl; 2012 Jan; 51(2):445-9. PubMed ID: 22110006
[TBL] [Abstract][Full Text] [Related]
14. Transferrin-Dressed Virus-like Ternary Nanoparticles with Aggregation-Induced Emission for Targeted Delivery and Rapid Cytosolic Release of siRNA.
Zhang T; Guo W; Zhang C; Yu J; Xu J; Li S; Tian JH; Wang PC; Xing JF; Liang XJ
ACS Appl Mater Interfaces; 2017 May; 9(19):16006-16014. PubMed ID: 28447465
[TBL] [Abstract][Full Text] [Related]
15. Novel siRNA delivery strategy: a new "strand" in CNS translational medicine?
Gherardini L; Bardi G; Gennaro M; Pizzorusso T
Cell Mol Life Sci; 2014 Jan; 71(1):1-20. PubMed ID: 23508806
[TBL] [Abstract][Full Text] [Related]
16. The emerging potential of siRNA nanotherapeutics in treatment of arthritis.
Kumari A; Kaur A; Aggarwal G
Asian J Pharm Sci; 2023 Sep; 18(5):100845. PubMed ID: 37881798
[TBL] [Abstract][Full Text] [Related]
17. In-Vitro Application of Magnetic Hybrid Niosomes: Targeted siRNA-Delivery for Enhanced Breast Cancer Therapy.
Maurer V; Altin S; Ag Seleci D; Zarinwall A; Temel B; Vogt PM; Strauß S; Stahl F; Scheper T; Bucan V; Garnweitner G
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33809700
[TBL] [Abstract][Full Text] [Related]
18. Triggering RNAi with multifunctional RNA nanoparticles and their delivery.
Dao BN; Viard M; Martins AN; Kasprzak WK; Shapiro BA; Afonin KA
DNA RNA Nanotechnol; 2015 Jan; 2(1):1-12. PubMed ID: 34322586
[TBL] [Abstract][Full Text] [Related]
19. Delivery of siRNA using cationic rosette nanotubes for gene silencing.
Ho U; El-Bakkari M; Alshamsan A; Cho JY; Yamazaki T; Hemraz UD; Fenniri H
Biomater Sci; 2023 Oct; 11(21):7169-7178. PubMed ID: 37734448
[TBL] [Abstract][Full Text] [Related]
20. Human β-Defensin 23 as a Carrier for In Vitro and In Vivo Delivery of mRNA.
Kim KR; Kim J; Cho S; Ahn DR
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
